| pubmed-article:1574917 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C0039614 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C0003445 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:1574917 | lifeskim:mentions | umls-concept:C0857515 | lld:lifeskim |
| pubmed-article:1574917 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1574917 | pubmed:dateCreated | 1992-6-2 | lld:pubmed |
| pubmed-article:1574917 | pubmed:abstractText | Tetanus immune globulin (TIG) continues to be recommended in persons with tetanus-prone wounds who have incomplete or unknown tetanus immunization status. The aim of this study was to determine whether, following a booster dose of tetanus toxoid in adults who had not been immunized in the previous 10 years, there was an antitoxin response to tetanus toxoid booster within 4 days. Thirty-one adults were investigated, baseline levels for tetanus antitoxin assayed using an ELISA technique, and an injection of adsorbed tetanus toxoid (0.5 ml) given. Blood samples for tetanus antitoxin levels were taken at daily intervals for the 4 days following immunization. Tetanus boosters following the primary course but before the present study did not significantly increase the levels of pre-study tetanus antitoxin and following the study booster there was no difference between the preboost levels and the levels on days 1 to 4. This finding indicates that the present recommendations for the use of TIG in tetanus-prone wounds are appropriate. | lld:pubmed |
| pubmed-article:1574917 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1574917 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1574917 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1574917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1574917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1574917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1574917 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1574917 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:CorbelM JMJ | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:WatkinsJ TJT | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:BeggN TNT | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:FarringtonC... | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:PorterJ DJD | lld:pubmed |
| pubmed-article:1574917 | pubmed:author | pubmed-author:PerkinM AMA | lld:pubmed |
| pubmed-article:1574917 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1574917 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:1574917 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1574917 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1574917 | pubmed:pagination | 334-6 | lld:pubmed |
| pubmed-article:1574917 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:meshHeading | pubmed-meshheading:1574917-... | lld:pubmed |
| pubmed-article:1574917 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1574917 | pubmed:articleTitle | Lack of early antitoxin response to tetanus booster. | lld:pubmed |
| pubmed-article:1574917 | pubmed:affiliation | Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK. | lld:pubmed |
| pubmed-article:1574917 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1574917 | lld:pubmed |
